Answers are grounded in this paper and cite their sources.
The rise of macrocyclic peptides as a therapeutic modality has exposed gaps in the synthetic chemistry toolbox available for drug discovery teams to rapidly explore diverse linkers for structural optimization. In contrast to the thioether linkers common in peptide leads identified from mRNA display, all-carbon linkers are desirable for imparting solubility and stability, but existing approaches suffer from limited amino acid diversity, incompatibility with solid-phase peptide synthesis (SPPS), stereochemical loss, multistep requirements, or restricted linker placement. We report a Doubly DeAminative Macrocyclization (D2AM) to install alkyl linkers via C(sp3)–C(sp3) bond formation. This method uses pyridinium monomers derived from commercial amino acids that are stable to SPPS for the seamless synthesis of complex macrocyclic and polycyclic peptides with conservation of stereochemistry. This deaminative method is anticipated to accelerate optimization of peptide macrocycle structure in drug discovery.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: